|
1.
|
2023/09/01
|
|
Lean nonalcoholic fatty liver disease: Age-dependent differences in pathology, prognosis, and liver-related events
|
|
2.
|
2023/08/12
|
|
Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia
|
|
3.
|
2023/05/10
|
|
Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis
|
|
4.
|
2022/06/07
|
|
Helicobacter pylori-Negative Advanced Gastric Cancer Arising from the Gastric Mucosa without Inflammation, Atrophy, or Intestinal Metaplasia
|
|
5.
|
2022/06/07
|
|
Two Cases of Acute Gastric Mucosal Lesions Due to Helicobacter pylori Infection Confirmed to be Transient Infection
|
|
6.
|
2022/05/11
|
|
A case of synchronous triple cancer of the esophagus, stomach, and colon detected by using gastrointestinal screening endoscopy
|
|
7.
|
2022/05/11
|
|
Severe grade of melanosis coli is associated with a higher detection rate of colorectal adenoma
|
|
8.
|
2022/05/05
|
|
Asymptomatic gangrenous cholecystitis diagnosed using contrast-enhanced ultrasonography in a patient with pancreatic cancer
|
|
9.
|
2022/04/12
|
|
Efficacy of primary drainage by endoscopic ultrasound-guided biliary drainage for unresectable pancreatic adenocarcinoma
|
|
10.
|
2022/03
|
|
Afferent-Loop Syndrome Treated with Endoscopic Ultrasound-Guided Drainage of the Afferent Loop with a Plastic Stent
|
|
11.
|
2022/03
|
|
Clinicopathological Features of Superficial Non-ampullary Duodenal Epithelial Tumors and Their Association with Gastric Mucosal Atrophy
|
|
12.
|
2022/03
|
|
Diagnosis of histological gastritis based on the Kyoto classification of gastritis in Japanese subjects – including evaluation of aging and sex difference of histological gastritis.
|
|
13.
|
2022/03
|
|
Evaluation of Helicobacter pylori-associated Gastritis Based on Gastrointestinal Barium X-ray Radiography Through the Comprehensive Health Checkup System: A Prospective, Observational Study
|
|
14.
|
2022/01
|
|
Diagnostic ability of linked color imaging in ultraslim endoscopy to identify neoplastic lesions in the upper gastrointestinal tract
|
|
15.
|
2022
|
|
Portal Hypertensive Gastropathy in Liver Cirrhosis: Prevalence, Natural History, and Risk Factors
|
|
16.
|
2021/10/18
|
|
Increased Colonic Fluorodeoxyglucose Uptake in Melanosis Coli—A Case Series of Three Patients
|
|
17.
|
2021/08/06
|
|
Surgical retrieval under general anesthesia of an inadvertent denture ingestion causing cervical esophageal perforation
|
|
18.
|
2021/05/27
|
|
Combination of type Ⅳ collagen 7S, albumin concentration, and platelet count predicts prognosis of non-alcoholic fatty liver disease
|
|
19.
|
2021/05/01
|
|
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years.
|
|
20.
|
2021/04/01
|
|
Gastric Hyperplastic Polyps after Argon Plasma Coagulation for Gastric Antral Vascular Ectasia in Patients with Liver Cirrhosis-A Case Suggesting the "Gastrin Link Theory".
|
|
21.
|
2021/02/19
|
|
Inflammatory cell numbers in the stomach of Japanese subjects with endoscopically normal mucosa without H.pylori infection.
|
|
22.
|
2021/02/18
|
|
Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis
|
|
23.
|
2021/01
|
|
Differences in emergency endoscopy outcomes according to gastrointestinal bleeding location
|
|
24.
|
2021/01
|
|
Linked Color Imaging Focused on Neoplasm Detection in the Upper Gastrointestinal Tract : A Randomized Trial
|
|
25.
|
2021
|
|
A Case of Successful Colon Stenting for Abscess due to Gallbladder Colon Fistula Caused by Gallbladder Cancer
|
|
26.
|
2020/09/04
|
|
Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals:A Cross-Sectional Study
|
|
27.
|
2020
|
|
Efficacy and safety of temporary biliary stent for prevention of post-ERCP cholangitis after endoscopic common bile duct stone removal :a retrospective study
|
|
28.
|
2019/10/15
|
|
High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis
|
|
29.
|
2019/09/27
|
|
Four cases of gastric cancer in patients with autoimmune gastritis
|
|
30.
|
2019/08
|
|
The role of Kyoto classification in the diagnosis of Helicobacter pylori infection and histologic gastritis among young subjects in Japan
|
|
31.
|
2018/05
|
|
Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy
|
|
32.
|
2017/10
|
|
Effective Biomarkers for advance fibrosis NASH and reflect biomarkers as changes of liver fibrosis with NASH
|
|
33.
|
2017/10
|
|
Prediction of hepatocellular carcinoma following direct-acting antiviral treatment for chronic hepatitis C
|
|
34.
|
2017/10
|
|
Sequential PEG-IFNa-2a and TDF+PEG-IFNa-2a combination therapy after long-term nucleic acid analog treatment effectively reduce hepatitis B surface antigten levels
|
|
35.
|
2017/04
|
|
Case report of diet-related improvements of non-alcoholic steatohepatitis evaluated by four consecutive liver biopsies
|
|
36.
|
2016/11
|
|
The association with non-alcoholic steatohepatitis and autoimmune gastritis-Coincidence or true nature?
|
|
37.
|
2016/11
|
|
The role of Kyoto classification for the diagnosis of Helicobacter pylori infection in young patients
|
|
38.
|
2016/10
|
|
Elevated WFAM2BP, ALT flare and HBs decline>1.0Log/ml during Peg IFN were predict drug free and HBs antigen clearance in sequential therapy with Peg-IFN alfa-2a on long-term nucleoside analog treated patients
|
|
39.
|
2016/10
|
|
The level of the macrophage activation marker soluble CD163 is apredictor of fibrosis progression and inflammation in non-alcoholic steatohepatitis(NASH)
|
|
40.
|
2016/10
|
|
The level of WFA+M2BP levels and alpha-fetoprotein levels are predicted hepatocellular carcinoma after sustained virologic response with chronic hepatitis C patients
|
|
41.
|
2015
|
|
Correlation between serum cytokeratin-18 and the progression or regression of non-alcoholic fatty liver disease
|
|
42.
|
2015
|
|
Elevated Serum Levels of M2BPGI Predict the Burned Out NASH and Hepatocellular Carcinoma with Non-Alcoholic Steatohepatitis
|
|
43.
|
2015
|
|
Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
|
|
44.
|
2014/11
|
|
Effect of achieving drug-free status and HBs antigen decline in sequential therapy with Peg-IFN alfa-2a on long-term nucleoside analog treated patients.
|
|
45.
|
2014/11
|
|
WFA-M2BP levels are usefull indicators of progression and improvement for monitoring liver fibrosis in patients with nonalcoholic steatohepatitis/ nonalcoholic fatty liver disease.
|
|
46.
|
2014/03
|
|
Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy.
|
|
47.
|
2013/12
|
|
A Case of Acute Superior Mesenteric Artery Embolism with Severe Ischemic Liver Injury Successfully Treated by Endovascular Treatment.
|
|
48.
|
2013/03
|
|
Treatment of nonalcoholic steatohepatitis with vitamins E and C:a pilot study
|
|
49.
|
2012/09
|
|
A prospective study showing poor prognosis in Japanese NASH patients with fibrosis stage F3-4
|
|
50.
|
2009/07
|
|
Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis.
|
|
51.
|
2005/04
|
|
Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.
|
|
52.
|
2004/05
|
|
Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis: a pilot study.
|
|
53.
|
2004/02
|
|
Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C.
|
|
Display 5 items
|
|
Display all(53)
|
